PainTEQ Obtains Patent for Advanced SI Joint Fusion Technology
New Patent Strengthens PainTEQ's Position in Minimally Invasive Treatments for SI Joint Dysfunction
PainTEQ, a frontrunner in the realm of minimally invasive treatments for sacroiliac (SI) joint dysfunction, has successfully secured a groundbreaking patent (US Patent No. 12,121,458). This notable achievement represents a key step in enhancing its innovative LinQ® SI Joint Stabilization System. The newly-awarded patent not only broadens PainTEQ's portfolio of single-use instruments but also safeguards its leading-edge design features aimed at improving procedural precision, efficiency, and patient safety.
Innovative Features Introduced with the New Patent
This patent comes with significant advancements focused on instrument alignment, reflecting PainTEQ's commitment to reducing surgical complications and improving overall patient outcomes. The new features introduced are:
Enhanced Alignment Mechanism
- Claims 1-6 highlight the implementation of a joint locator equipped with a protruding key, ensuring seamless alignment with the cannula thanks to its guidance slot.
- Claims 7-12 expand the innovation even further by incorporating a design where the protrusion is located on the cannula, while the joint locator features a channel that fits this protrusion appropriately.
These advancements combine to forge a unique and effective approach that greatly elevates the accuracy of surgical procedures, ultimately leading to better results for patients.
A Leap Forward in Treatment
Dr. Sudir Diwan, a renowned Pain Management Physician and President of Advanced Spine on Park Avenue, expressed enthusiasm about the progress. He remarked, "LINQ's SI joint fusion represents a significant leap in our efforts to treat sacroiliac joint dysfunction, surpassing conventional lateral options. Its precision-driven, minimally invasive design not only enhances patient outcomes but also considerably shortens recovery periods. I've witnessed how this innovative approach can be life-changing, facilitating a swift return to normal activities for patients with confidence and ease."
Reinforcing Intellectual Property and Future Roadmap
The new patent further solidifies PainTEQ's intellectual property base, which incorporates pioneering advancements in alignment tools. Such patented technologies streamline surgical procedures, minimize variability in patient outcomes, and prioritize safety through the use of intuitive, single-use designs that foster efficiency in outpatient settings.
Jeremy Carr, PainTEQ's Director of Marketing and R&D, stated, "Our mission at PainTEQ is to revolutionize the treatment landscape for SI joint dysfunction, and this patent reinforces our focus on delivering innovative solutions that prioritize the well-being of the patient. By consistently pushing the envelope and broadening the capabilities of our LinQ® System, we are not only elevating industry standards but also enhancing the quality of life for countless individuals burdened with SI joint pain."
About PainTEQ
PainTEQ's foundation is built upon the commitment to introduce effective interventional procedures into the market. Collaborating closely with pain management specialists, PainTEQ aims to mitigate and eradicate SI joint dysfunction through advanced technology. Their LinQ implant and specifically designed single-use instruments provide immediate clinical benefits for individuals grappling with debilitating lower back pain through minimally invasive outpatient procedures.
About LinQ Technology
The LinQ SI Joint Stabilization System offers an innovative, minimally invasive solution for managing pain stemming from sacroiliac disease. Following a comprehensive diagnostic evaluation, healthcare providers may alleviate, and in many cases eliminate, chronic pain by implanting a single LinQ allograft into the SI joint. The design includes a broader graft window and specialized instrumentation, ensuring an ideal environment for long-term fusion while emphasizing operational accuracy and efficiency.
Frequently Asked Questions
1. What is PainTEQ's new patent about?
PainTEQ's new patent focuses on advancements in its LinQ® SI Joint Stabilization System, particularly in enhancing instrument alignment, procedural precision, and patient safety.
2. How does the new patent improve SI joint fusion?
The patent introduces mechanisms that provide seamless alignment during procedures, reducing the risk of complications and improving overall patient outcomes.
3. Who is Dr. Sudir Diwan?
Dr. Sudir Diwan is a Pain Management Physician and President of Advanced Spine on Park Avenue, who advocates for the innovative treatments provided by PainTEQ.
4. What is the significance of PainTEQ's intellectual property?
The newly secured patent strengthens PainTEQ's intellectual property portfolio, allowing it to maintain a competitive edge in the minimally invasive SI joint treatment market.
5. How does the LinQ System work?
The LinQ System alleviates pain by implanting an allograft into the SI joint, designed to promote long-term fusion and enhance patient recovery post-surgery.
